Hi guys,
Not sure if this has been discussed yet , but read this.
A BARDA official said last week that the agency does not have safety worries about the drug, laninamivir octanoate, but that concerns had arisen about the enrollment of subjects in clinical trials, the cost of additional trials, the “emergence of resistance to laninamivir in recent H7N9 virus strains, and the feasibility of laninamivir for treatment of critically ill, hospitalized patients with influenza.”
http://www.ajc.com/news/business/feds-kill-alpharetta-drug-firms-contract-for-flu-t/nfrZB/
Hi guys,Not sure if this has been discussed yet , but read...
Add to My Watchlist
What is My Watchlist?